AP - Boston Scientific Corp. on Monday said its first-quarter profit fell by 64 percent on weak sales of the medical device maker's top-selling product as well as costs from the company's $27 billion acquisition of Guidant Corp. last spring.
AP - Boston Scientific Corp. on Monday said its first-quarter profit fell by 64 percent on weak sales of the medical device maker's top-selling product as well as costs from the company's $27 billion acquisition of Guidant Corp. last spring.
No comments:
Post a Comment